Cash Flows (Details) - USD ($)
$ in Millions |
3 Months Ended |
12 Months Ended |
Dec. 28, 2019 |
Sep. 28, 2019 |
Jun. 29, 2019 |
Mar. 30, 2019 |
Dec. 29, 2018 |
Sep. 29, 2018 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Dec. 28, 2019 |
Dec. 29, 2018 |
Dec. 30, 2017 |
| Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
$ 92
|
$ 106
|
$ 116
|
$ 71
|
$ 100
|
$ 114
|
$ 126
|
$ 67
|
$ 385
|
$ 407
|
$ 444
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
| Deferred tax provision (benefit) |
|
|
|
|
|
|
|
|
7
|
45
|
(123)
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
| (Decrease) increase in accrued expenses and other liabilities |
|
|
|
|
|
|
|
|
(4)
|
(126)
|
41
|
| Net cash provided by operating activities |
|
|
|
|
|
|
|
|
760
|
609
|
749
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
| Net cash used in investing activities |
|
|
|
|
|
|
|
|
(1,987)
|
(232)
|
(356)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
| Common stock repurchased |
|
|
|
|
|
|
|
|
0
|
0
|
(280)
|
| Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
1,220
|
(391)
|
(405)
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
(7)
|
(14)
|
(12)
|
| Cash, cash equivalents and restricted cash—beginning of year |
|
|
|
105
|
|
|
|
119
|
105
|
119
|
131
|
| Cash, cash equivalents and restricted cash—end of year |
98
|
|
|
|
105
|
|
|
|
98
|
105
|
119
|
| US Foods Holding Corp. |
|
|
|
|
|
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
| Net income |
|
|
|
|
|
|
|
|
385
|
407
|
444
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
| Equity in net earnings of subsidiary |
|
|
|
|
|
|
|
|
(385)
|
(376)
|
(439)
|
| Deferred tax provision (benefit) |
|
|
|
|
|
|
|
|
0
|
(23)
|
(77)
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
|
|
|
| Decrease in other assets |
|
|
|
|
|
|
|
|
0
|
0
|
1
|
| (Decrease) increase in accrued expenses and other liabilities |
|
|
|
|
|
|
|
|
0
|
(8)
|
71
|
| Net cash provided by operating activities |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
| Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
| Cash distribution from subsidiary |
|
|
|
|
|
|
|
|
0
|
0
|
280
|
| Net cash used in investing activities |
|
|
|
|
|
|
|
|
0
|
0
|
280
|
| Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
| Common stock repurchased |
|
|
|
|
|
|
|
|
0
|
0
|
(280)
|
| Net cash provided by (used in) financing activities |
|
|
|
|
|
|
|
|
0
|
0
|
(280)
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
|
|
|
|
0
|
0
|
0
|
| Cash, cash equivalents and restricted cash—beginning of year |
|
|
|
$ 0
|
|
|
|
$ 0
|
0
|
0
|
0
|
| Cash, cash equivalents and restricted cash—end of year |
$ 0
|
|
|
|
$ 0
|
|
|
|
$ 0
|
$ 0
|
$ 0
|